Certoparin (trade names Sandoparin, Embolex) is an antithrombotic medication. It is a low molecular weight heparin, primarily active against factor Xa. Like other low molecular weight heparins, it is used to prevent deep venous thrombosis.[1]
 | |
| Clinical data | |
|---|---|
| Trade names | Sandoparin, Embolex |
| AHFS/Drugs.com | International Drug Names |
| ATC code |
|
| Identifiers | |
| DrugBank | |
| ChemSpider |
|
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.110.590 |
References
edit- ^ Donadini MP, Ageno W, Guasti L, Squizzato A (July 2013). "Certoparin for the treatment and prevention of thrombosis: pharmacological profile and results from clinical studies". Expert Opinion on Drug Metabolism & Toxicology. 9 (7): 901–9. doi:10.1517/17425255.2013.794787. PMID 23621639. S2CID 31020741.
 | This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it. |